REPORT DESCRIPTION
Molecular Cytogenetics Market is Expected to Reach USD 1.97 Billion Globally in
2019: Transparency Mark...
Browse the full report at
http://www.transparencymarketresearch.com/molecular-diagnostics-
market.html
However, breakthrou...
significant growth and emerge as the fastest growing segment during analysis period with a
CAGR of more than 20%.
The grow...
Browse the full report at
http://www.transparencymarketresearch.com/molecular-diagnostics-
market.html
Chapter 2 Executive...
3.7.1 Global Molecular Cytogenetics Market Share Analysis, by Key Players (%)
3.8 End User Analysis
3.8.1 Global Molecular...
Chapter 6 Molecular Cytogenetics Market, by Geography
6.1 Overview
6.1.1 Global Molecular Cytogenetics Market, by Geograph...
Browse the full report at
http://www.transparencymarketresearch.com/molecular-diagnostics-
market.html
Chapter 8 Company P...
8.4.4 Business Strategy
8.5 BI Biological Industries
8.5.1 Company Overview
8.5.2 Financial Overview
8.5.3 Product Portfol...
8.9.3 Product Portfolio
8.9.4 Business Strategy
8.9.5 Recent Developments
8.10 Illumina Inc.
8.10.1 Company Overview
8.10....
8.13.4 Business Strategy
8.13.5 Recent Developments
8.14 PerkinElmer, Inc.
8.14.1 Company Overview
8.14.2 Financial Overvi...
Upcoming SlideShare
Loading in …5
×

Global Molecular Cytogenetics Market (2013 – 2019)

207 views

Published on

Transparency Market Research published new market report "Molecular Cytogenetics Market (Technologies: FISH and aCGH; Applications: Genetic Disorders, Cancer and Personalized Medicine) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019," the global molecular cytogenetics market was valued at USD 469.2 million in 2012 and is estimated to reach a market worth USD 1.97 billion in 2019 at a CAGR of 23.4% from 2013 to 2019.


Browse the report With Full TOC at http://www.transparencymarketresearch.com/molecular-diagnostics-market.html

0 Comments
0 Likes
Statistics
Notes
  • Be the first to comment

  • Be the first to like this

No Downloads
Views
Total views
269
On SlideShare
0
From Embeds
0
Number of Embeds
0
Actions
Shares
0
Downloads
5
Comments
0
Likes
0
Embeds 0
No embeds

No notes for slide

Global Molecular Cytogenetics Market (2013 – 2019)

  1. 1. REPORT DESCRIPTION Molecular Cytogenetics Market is Expected to Reach USD 1.97 Billion Globally in 2019: Transparency Market Research Transparency Market Research published new market report "Molecular Cytogenetics Market (Technologies: FISH and aCGH; Applications: Genetic Disorders, Cancer and Personalized Medicine) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019," the global molecular cytogenetics market was valued at USD 469.2 million in 2012 and is estimated to reach a market worth USD 1.97 billion in 2019 at a CAGR of 23.4% from 2013 to 2019. Molecular cytogenetics is emerging as an indispensable tool in the field of research and diagnosis. Until the advent of molecular cytogenetics techniques in 1980s, chromosomal analysis was mainly based on banding patterns. Although, the traditional banding techniques encountered problems such as low resolution and poor quality analysis. Transparency Market Research Molecular Cytogenetics Market (Technologies: FISH and aCGH; Applications: Genetic Disorders And Cancer) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 – 2019 Multi User License: US $ 7595 Corporate User License: US $ 10595 Buy Now Request Sample Published Date: Aug 2013 96 Pages Report
  2. 2. Browse the full report at http://www.transparencymarketresearch.com/molecular-diagnostics- market.html However, breakthrough in fluorescence in situ hybridization (FISH) and array-comparative genomic hybridization (aCGH) techniques has enhanced the diagnosis of chromosomal anomalies particularly in tumor and hematological malignancies. Nowadays, cytogenetics techniques are being considered mandatory in diagnosis and prognosis of leukemia. The techniques are considered as a standard laboratory test since they provide global screening of abnormalities. The scope of molecular cytogenetics is increasing with the rising cancer incidences worldwide and growing popularity of personalized medicines. The ability of FISH technique to study cells at an interphase stage of the cell cycle has made the technique a breakthrough in molecular cytogenetics field. FISH technique is used in the research of diverse applications such as cancer, cardiovascular and genetic disorder. The impetus of FISH technique is a direct result of improved understanding of sequence, structure and function of human genome. Similarly, supported by technological advancements in fluorescent microscopes and digital imaging, FISH technique has emerged as a preferred tool in molecular cytogenetics. The technique facilitates the analysis of sub- chromosomal regions and the identifications of small translocations thereby, routinely used in clinical applications. Owing to the techniques' sensitivity and specificity, FISH is significantly used in number of cytogenetic and pathological laboratories. The advent of aCGH is ushering new standards for the analysis of genome. The technology has turned out to be a greatest driver for the molecular cytogenetics market as it is overcoming the resolution problems associated with traditional banding techniques. aCGH is poised to witness a significant growth in the market and is likely to emerge as the fastest growing technology segment. aCGH has propelled the cytogenetics market from the microscopes to computers and thus, facilitated simultaneous analysis of thousands of discrete regions of the genome. Similarly, the technique is gaining popularity as one assay performed on this technique is comparable to thousands of FISH experiments and hence, saves time and cost. Moreover, the technique is expected to rapidly supplant FISH technique owing to further technological advancements in the technique. Likewise, increasing sensitivity of the aCGH technique is preferred as a primary diagnosis tool followed by validation with FISH. The technique is emerging as a powerful tool for high resolution analysis of sub-microscopic chromosomal abnormalities. aCGH is also evolving as a method of choice for molecular cytogenetics by the researchers owing to its work flow advantages and cost effectiveness. North America accounts for the largest share of the molecular cytogenetics market followed by the European region. The markets for these regions are driven by factors such as increased level of public awareness, rising cancer incidences and large number of research institutes engaged in cytogenetics field. However, Asia-Pacific region is likely to emerge as the fastest growing region over the analysis period. Cancer diagnosis is likely to witness a
  3. 3. significant growth and emerge as the fastest growing segment during analysis period with a CAGR of more than 20%. The growing demand for molecular cytogenetics techniques in research and data interpretation has resulted in quick expansion of manufacturers' product portfolio. The manufacturers are focused on building aggressive strategies for the development of innovative products that would cater research and diagnostic sectors. The vendors are eager to tap the emerging regions and end-users of this market. Major players engaged in development of innovative molecular cytogenetics techniques are Abbott laboratories, Affymetrix, Inc., Applies Spectral Imaging, BI Biological Industries, Life Technologies Corporation, Roche Diagnostics, Oxford Gene Technology, Illumina, Inc., among others. The molecular cytogenetics market is segmented as follows: Molecular Cytogenetics Market, by Technology  FISH  aCGH Molecular Cytogenetics Market, by Application  Genetic Disorders  Cancer  Personalized Medicine  Others Molecular Cytogenetics Market, by Geography  North America  Europe  Asia-Pacific  RoW TABLE OF CONTENTS Chapter 1 Preface 1.1 Report Description 1.2 Market Segmentation 1.3 Research Methodology
  4. 4. Browse the full report at http://www.transparencymarketresearch.com/molecular-diagnostics- market.html Chapter 2 Executive Summary 2.1 Market Snapshot: Global Molecular Cytogenetics Market (2012 & 2019) 2.2 Global Molecular Cytogenetics Market, by Technology, 2012 (USD Million) 2.3 Global Molecular Cytogenetics Market, by Application, 2012 (USD Million) Chapter 3 Market Overview 3.1 Introduction 3.2 Market Drivers 3.2.1 Introduction of advanced technologies 3.2.2 Rising incidence of cancer cases 3.3 Market Restraints 3.3.1 Issues with medical reimbursement 3.4 Market Opportunities 3.4.1 Advent of Next Generation Sequencing 3.4.2 Tapping the emerging economies 3.5 Porter’s Five Forces Analysis 3.5.1 Bargaining power of buyers 3.5.2 Bargaining power of suppliers 3.5.3 Threat of new entrants 3.5.4 Threat of substitutes 3.5.5 Competitive rivalry 3.6 Market Attractiveness Analysis 3.7 Market Share Analysis, by Key Players (%)
  5. 5. 3.7.1 Global Molecular Cytogenetics Market Share Analysis, by Key Players (%) 3.8 End User Analysis 3.8.1 Global Molecular Cytogenetics End User Analysis Chapter 4 Molecular Cytogenetics Market, by Technology 4.1 Overview 4.1.1 Global Molecular Cytogenetics Market, by Technology, 2011 – 2019 (USD Million) 4.2 Fluorescence in situ hybridization (FISH) 4.2.1 Global FISH Market, 2011 – 2019 (USD Million) 4.3 Array-Comparative Genomic Hybridization (aCGH) 4.3.1 Global aCGH Market, 2011 – 2019 (USD Million) Chapter 5 Molecular Cytogenetics Market, by Applications 5.1 Overview 5.1.1 Global Molecular Cytogenetics Market, by Application, 2011 – 2019 (USD Million) 5.2 Cancer 5.2.1.1 Global Cancer Application Market, 2011 – 2019 (USD Million) 5.3 Personalized Medicines 5.3.1.1 Global Personalized Medicine Application Market, 2011 – 2019 (USD Million) 5.4 Genetic Disorders 5.4.1.1 Global Genetic Disorder Application Market, 2011 – 2019 (USD Million) 5.5 Others (Neurological, Cardiovascular and Infectious Diseases) 5.5.1.1 Global Others Application Market, 2011 – 2019 (USD Million)
  6. 6. Chapter 6 Molecular Cytogenetics Market, by Geography 6.1 Overview 6.1.1 Global Molecular Cytogenetics Market, by Geography, 2011 – 2019 (USD Million) 6.2 Comparative Analysis: Molecular Cytogenetics Market, by Geography, 2012 & 2019 (Value %) 6.3 North America 6.3.1 North America Molecular Cytogenetics Market, by Technology, 2011 – 2019 (USD Million) 6.3.2 North America Molecular Cytogenetics Market, by Applications, 2011 – 2019 (USD Million) 6.4 Europe 6.4.1 Europe Molecular Cytogenetics Market, by Technology, 2011 – 2019 (USD Million) 6.4.2 Europe Molecular Cytogenetics Market, by Applications, 2011 – 2019 (USD Million) 6.5 Asia-Pacific 6.5.1 Asia-Pacific Molecular Cytogenetics Market, by Technology, 2011 – 2019 (USD Million) 6.5.2 Asia-Pacific Molecular Cytogenetics Market, by Applications, 2011 – 2019 (USD Million) 6.6 RoW 6.6.1 RoW Molecular Cytogenetics Market, by Technology, 2011 – 2019 (USD Million) 6.6.2 RoW Molecular Cytogenetics Market, by Applications, 2011 – 2019 (USD Million) Chapter 7 Recommendations 7.1 Investment in emerging economies 7.2 Mergers and Acquisitions
  7. 7. Browse the full report at http://www.transparencymarketresearch.com/molecular-diagnostics- market.html Chapter 8 Company Profiles 8.1 Abbott Laboratories 8.1.1 Company Overview 8.1.2 Financial Overview 8.1.3 Product Portfolio 8.1.4 Business Strategies 8.1.5 Recent Developments 8.2 Affymetrix, Inc. 8.2.1 Company Overview 8.2.2 Financial Overview 8.2.3 Product Portfolio 8.2.4 Business Strategy 8.2.5 Recent Developments 8.3 Agilent Technologies, Inc. 8.3.1 Company Overview 8.3.2 Financial Overview 8.3.3 Product Portfolio 8.3.4 Business Strategies 8.3.5 Recent Developments 8.4 Applied Spectral Imaging, Inc. 8.4.1 Company Overview 8.4.2 Financial Overview 8.4.3 Product Portfolio
  8. 8. 8.4.4 Business Strategy 8.5 BI Biological Industries 8.5.1 Company Overview 8.5.2 Financial Overview 8.5.3 Product Portfolio 8.5.4 Business Strategy 8.6 Bio-Rad Laboratories 8.6.1 Company overview 8.6.2 Financial Overview 8.6.3 Product Portfolio 8.6.4 Business Strategies 8.6.5 Recent Developments 8.7 CytoTest Inc. 8.7.1 Company Overview 8.7.2 Financial Overview 8.7.3 Product Portfolio 8.7.4 Business Strategy 8.8 Cytognomix, Inc. 8.8.1 Company Overview 8.8.2 Financial Overview 8.8.3 Product Portfolio 8.8.4 Recent Developments 8.9 F. Hoffmann-La Roche Ltd. 8.9.1 Company Overview 8.9.2 Financial Overview
  9. 9. 8.9.3 Product Portfolio 8.9.4 Business Strategy 8.9.5 Recent Developments 8.10 Illumina Inc. 8.10.1 Company Overview 8.10.2 Financial Overview 8.10.3 Product Portfolio 8.10.4 Business Strategies 8.10.5 Recent Developments 8.11 LEICA BIOSYSTEMS 8.11.1 Company Overview 8.11.2 Financial Overview 8.11.3 Product Portfolio 8.11.4 Business Strategy 8.11.5 Recent Development 8.12 Life Technologies Corporation 8.12.1 Company Overview 8.12.2 Financial Overview 8.12.3 Product Portfolio 8.12.4 Business Strategy 8.12.5 Recent Developments 8.13 Oxford Gene Technology 8.13.1 Company Overview 8.13.2 Financial Overview 8.13.3 Product Portfolio
  10. 10. 8.13.4 Business Strategy 8.13.5 Recent Developments 8.14 PerkinElmer, Inc. 8.14.1 Company Overview 8.14.2 Financial Overview 8.14.3 Product Portfolio 8.14.4 Business Strategy 8.14.5 Recent Developments 8.15 SciGene Corporation 8.15.1 Company Overview 8.15.2 Financial Overview 8.15.3 Product Portfolio About Us: Transparency Market Research is a market intelligence company providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. We are privileged with highly experienced team of Analysts, Researchers and Consultants, who use proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge. Contact: Transparency Market Research 90 State Street, Suite 700, Albany NY - 12207 United States Tel: +1-518-618-1030 USA - Canada Toll Free 866-552-3453 Email: sales@transparencymarketresearch.com Website: http://www.transparencymarketresearch.com/

×